𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Development of a dosimetry inter-comparison for IMRT as part of site credentialing for a TROG multi-centre clinical trial for prostate cancer

✍ Scribed by B. Healy; J. Frantzis; R. Murry; J. Martin; M. Middleton; C. Catton; T. Kron

Book ID
107693389
Publisher
Springer Netherlands
Year
2011
Tongue
English
Weight
230 KB
Volume
34
Category
Article
ISSN
0158-9938

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Can multiparametric magnetic resonance i
Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology?11Mohamed Abd-Alazeez receives funding from the Egyptian government. Mark Emberton and Hashim U. Ahmed receive funding from USHIFU and Advanced Medical Diagnostics for clinical trials. Mark Emberton is a paid consultant for Steba Biotech, USHIFU and Sanofi-Aventis. Mark Emberton has received research support by GSK for a study evaluating the role of MRI in men with prostate cancer. Mark Emberton and Hashim Ahmed have previously received medical consultancy fees from GE Healthcare/Oncura and Hashim Ahmed previously from Steba Biotech. Mark Emberton is a medical director of Mediwatch PLC. Hashim Uddin Ahmed and Mark Emberton receive funding from the Medical Research Council, the NIHR-HTA, NIHR-i4i, the US NIH/NCI, Pelican Cancer Foundation, Prostate Cancer UK, and St PeterΧ³s Trust. This work was part funded by research support for Mark Emberton and Alex Kirkham from the UK National Institute of Health Research UCLH/UCL Comprehensive Biomedical Research Centre, London, UK.
✍ Abd-Alazeez, Mohamed; Ahmed, Hashim U.; Arya, Manit; Allen, Clare; Dikaios, Niko πŸ“‚ Article πŸ“… 2014 πŸ› Elsevier Science 🌐 English βš– 415 KB